OXGENE

Content by OXGENE

|2 min read

OXGENE Introduces TESSA Technology for Robust and Reproducible AAV Manufacture at Scale

Novel, plasmid-free manufacturing system reduces cost of goods and improves AAV quality to enable development of safer gene therapies
Page 1 of 1